BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 18024214)

  • 1. p19(Ink4d) and p21(Cip1) collaborate to maintain the postmitotic state of auditory hair cells, their codeletion leading to DNA damage and p53-mediated apoptosis.
    Laine H; Doetzlhofer A; Mantela J; Ylikoski J; Laiho M; Roussel MF; Segil N; Pirvola U
    J Neurosci; 2007 Feb; 27(6):1434-44. PubMed ID: 17287518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enigmatic effects of caffeine in cell cycle and cancer.
    Bode AM; Dong Z
    Cancer Lett; 2007 Mar; 247(1):26-39. PubMed ID: 16709440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 controls choice between apoptotic and non-apoptotic death following DNA damage.
    Honeywell ME; Isidor MS; Harper NW; Fontana RE; Cruz-Gordillo P; Porto SA; Fraser CS; Sarosiek KA; Guertin DA; Spinelli JB; Lee MJ
    bioRxiv; 2023 May; ():. PubMed ID: 36712034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinic acid and hypervalent chromium: a spectroscopic and kinetic study.
    Mangiameli MF; Bellú S; Pérez Mora B; Sala L; Mamana N
    RSC Adv; 2018 Aug; 8(51):29356-29367. PubMed ID: 35547999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexavalent chromium intoxication induces intrinsic and extrinsic apoptosis in human renal cells.
    Wu YH; Lin JC; Wang TY; Lin TJ; Yen MC; Liu YH; Wu PL; Chen FW; Shih YL; Yeh IJ
    Mol Med Rep; 2020 Feb; 21(2):851-857. PubMed ID: 31974625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA mismatch repair protein Mlh1 is required for tetravalent chromium intermediate-induced DNA damage.
    Wakeman TP; Yang A; Dalal NS; Boohaker RJ; Zeng Q; Ding Q; Xu B
    Oncotarget; 2017 Oct; 8(48):83975-83985. PubMed ID: 29137397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium.
    Kim D; Dai J; Park YH; Fai LY; Wang L; Pratheeshkumar P; Son YO; Kondo K; Xu M; Luo J; Shi X; Zhang Z
    J Biol Chem; 2016 Jul; 291(31):16271-81. PubMed ID: 27226640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr(VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance development.
    Kim D; Dai J; Fai LY; Yao H; Son YO; Wang L; Pratheeshkumar P; Kondo K; Shi X; Zhang Z
    J Biol Chem; 2015 Jan; 290(4):2213-24. PubMed ID: 25477514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of In Vivo Chromium with a Hollow-fiber Dialysis Sensor.
    Ly SY; Yoo HS; Jung M; Ko KH; Kim BJ; Lee KC; Choi BM
    Toxicol Res; 2010 Sep; 26(3):233-6. PubMed ID: 24278529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy.
    Hill R; Rabb M; Madureira PA; Clements D; Gujar SA; Waisman DM; Giacomantonio CA; Lee PW
    Cell Death Dis; 2013 Sep; 4(9):e791. PubMed ID: 24008735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexavalent chromium Cr(VI) up-regulates COX-2 expression through an NFκB/c-Jun/AP-1-dependent pathway.
    Zuo Z; Cai T; Li J; Zhang D; Yu Y; Huang C
    Environ Health Perspect; 2012 Apr; 120(4):547-53. PubMed ID: 22472290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of chromium (VI) apoptosis, cell-cycle-arrest, and carcinogenesis.
    Chiu A; Shi XL; Lee WK; Hill R; Wakeman TP; Katz A; Xu B; Dalal NS; Robertson JD; Chen C; Chiu N; Donehower L
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2010 Jul; 28(3):188-230. PubMed ID: 20859824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation by p53.
    Beckerman R; Prives C
    Cold Spring Harb Perspect Biol; 2010 Aug; 2(8):a000935. PubMed ID: 20679336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescence evasion by MCF-7 human breast tumor-initiating cells.
    Karimi-Busheri F; Rasouli-Nia A; Mackey JR; Weinfeld M
    Breast Cancer Res; 2010; 12(3):R31. PubMed ID: 20525204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension.
    Cheng J; Zhou W; Warner GM; Knudsen BE; Garovic VD; Gray CE; Lerman LO; Platt JL; Romero JC; Textor SC; Nath KA; Grande JP
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1055-68. PubMed ID: 19625373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells.
    Hill R; Leidal AM; Madureira PA; Gillis LD; Cochrane HK; Waisman DM; Chiu A; Lee PW
    DNA Repair (Amst); 2008 Feb; 7(2):239-52. PubMed ID: 18024214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
    Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
    Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.